Edition:
United Kingdom

Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

1,654JPY
19 Apr 2019
Change (% chg)

¥28 (+1.72%)
Prev Close
¥1,626
Open
¥1,650
Day's High
¥1,663
Day's Low
¥1,648
Volume
957,300
Avg. Vol
1,382,102
52-wk High
¥2,061
52-wk Low
¥1,450

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 7.13 March 20 Apr 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 0 0
(2) OUTPERFORM 3 4 4 4
(3) HOLD 4 5 6 6
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.56 2.55 2.73 2.73

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 1 60,300.00 60,300.00 60,300.00 --
Quarter Ending Dec-19 1 62,800.00 62,800.00 62,800.00 --
Year Ending Mar-19 9 234,756.00 238,000.00 231,600.00 230,470.00
Year Ending Mar-20 10 245,885.00 253,000.00 240,600.00 243,656.00
Earnings (per share)
Quarter Ending Sep-19 1 7.13 7.13 7.13 --
Quarter Ending Dec-19 1 11.31 11.31 11.31 --
Year Ending Mar-19 10 79.58 86.80 68.50 74.82
Year Ending Mar-20 11 80.50 98.30 50.63 83.28
LT Growth Rate (%) 1 4.60 4.60 4.60 7.40

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 61,149.00 58,866.00 2,283.00 3.73
Quarter Ending Sep-18 57,961.70 57,861.00 100.67 0.17
Quarter Ending Jun-18 58,817.80 56,483.00 2,334.75 3.97
Quarter Ending Mar-18 54,958.00 56,350.00 1,392.00 2.53
Quarter Ending Dec-17 58,288.70 57,818.00 470.67 0.81

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 60,300.00 60,300.00 60,200.00 60,200.00 --
Quarter Ending Dec-19 62,800.00 62,800.00 62,900.00 62,900.00 --
Year Ending Mar-19 234,756.00 234,756.00 235,812.00 236,312.00 230,470.00
Year Ending Mar-20 245,885.00 245,885.00 248,133.00 248,260.00 243,656.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 0 0 1 0
Quarter Ending Dec-19 0 0 0 1
Year Ending Mar-19 0 0 1 1
Year Ending Mar-20 0 0 0 2
Earnings